{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:43:47Z","timestamp":1785782627435,"version":"3.56.0"},"reference-count":98,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001174","name":"Houston Endowment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001174","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"Horizon 2020 MSCA","doi-asserted-by":"publisher","award":["101081481"],"award-info":[{"award-number":["101081481"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Neoplasia"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.bneo.2025.100090","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T13:34:42Z","timestamp":1741613682000},"page":"100090","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-7922-9321","authenticated-orcid":false,"given":"Hannah","family":"Kunstek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janneke","family":"Kieviet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-5620","authenticated-orcid":false,"given":"Caroline","family":"Lindemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3992-8570","authenticated-orcid":false,"given":"Coco","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3406-817X","authenticated-orcid":false,"given":"Stefan","family":"Nierkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bneo.2025.100090_bib1","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/asheducation-2015.1.215","article-title":"Immune reconstitution following stem cell transplantation","volume":"2015","author":"van den Brink","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6","key":"10.1016\/j.bneo.2025.100090_bib2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.2020007905","article-title":"CD4+ T-cell reconstitution predicts survival outcomes after acute graft-versus-host-disease: a dual-center validation","volume":"137","author":"de Koning","year":"2021","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4049\/jimmunol.1601100","article-title":"Immune reconstitution after allogeneic hematopoietic stem cell transplantation: time to T up the thymus","volume":"198","author":"Chaudhry","year":"2017","journal-title":"The Journal of Immunology"},{"issue":"5","key":"10.1016\/j.bneo.2025.100090_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41577-020-00457-z","article-title":"T cell regeneration after immunological injury","volume":"21","author":"Velardi","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.bneo.2025.100090_bib5","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3389\/fimmu.2018.00767","article-title":"Resetting the T cell compartment in autoimmune diseases with autologous hematopoietic stem cell transplantation: an update","volume":"9","author":"Lutter","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.bneo.2025.100090_bib6","first-page":"15","article-title":"The thymus road to a T cell: migration, selection, and atrophy","author":"Ruiz P\u00e9rez","year":"2024","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.bneo.2025.100090_bib7","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4049\/jimmunol.170.2.672","article-title":"Cutting edge: homeostatic proliferation of peripheral T lymphocytes is regulated by clonal competition1","volume":"170","author":"Troy","year":"2003","journal-title":"The Journal of Immunology"},{"issue":"5","key":"10.1016\/j.bneo.2025.100090_bib8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5501\/wjv.v9.i5.67","article-title":"Thymosin alpha 1: a comprehensive review of the literature","volume":"9","author":"Dominari","year":"2020","journal-title":"World J Virol"},{"issue":"12","key":"10.1016\/j.bneo.2025.100090_bib9","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1080\/14712598.2020.1800636","article-title":"Precursors of thymic peptides as stress sensors","volume":"20","author":"Lunin","year":"2020","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bneo.2025.100090_bib10","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1196\/annals.1415.025","article-title":"Signaling pathways leading to the activation of IKK and MAPK by thymosin \u03b11","volume":"1112","author":"Peng","year":"2007","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"15 suppl 1","key":"10.1016\/j.bneo.2025.100090_bib11","doi-asserted-by":"crossref","first-page":"S129","DOI":"10.1517\/14712598.2015.1007948","article-title":"Thymosin alpha-1 treatment in chronic hepatitis B","author":"Wu","year":"2015","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bneo.2025.100090_bib13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jvh.12807","article-title":"Immunotherapy for hepatitis B in the direct acting antiviral era: reevaluating the thymosin \u03b11 efficacy trials in the light of a combination therapy approach","volume":"25","author":"Naylor","year":"2018","journal-title":"J Viral Hepat"},{"issue":"12","key":"10.1016\/j.bneo.2025.100090_bib14","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1365-2036.2001.01135.x","article-title":"The efficacy of thymosin in the treatment of chronic hepatitis B virus infection: a meta-analysis","volume":"15","author":"Chan","year":"2001","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.bneo.2025.100090_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2217\/fmb-2016-0125","article-title":"Thymosin alpha 1 and HIV-1: recent advances and future perspectives","volume":"12","author":"Matteucci","year":"2017","journal-title":"Future Microbiol"},{"key":"10.1016\/j.bneo.2025.100090_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1749-6632.2010.05487.x","article-title":"Thymalfasin in the treatment of hepatitis B and C","volume":"1194","author":"Ciancio","year":"2010","journal-title":"Ann N Y Acad Sci"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2025.100090_bib17","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/14712598.2018.1484104","article-title":"Thymosin alpha 1 treatment for patients with sepsis","volume":"18","author":"Pei","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bneo.2025.100090_bib18","doi-asserted-by":"crossref","first-page":"110055","DOI":"10.1016\/j.intimp.2023.110055","article-title":"Thymosin alpha 1 restores the immune homeostasis in lymphocytes during post-acute sequelae of SARS-CoV-2 infection","volume":"118","author":"Minutolo","year":"2023","journal-title":"Int Immunopharmacol"},{"issue":"8","key":"10.1016\/j.bneo.2025.100090_bib19","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.3390\/molecules28083539","article-title":"Thymosin \u03b11 and its role in viral infectious diseases: the mechanism and clinical application","volume":"28","author":"Tao","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bneo.2025.100090_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2012.06716.x","article-title":"Jack of all trades: thymosin \u03b11 and its pleiotropy","volume":"1269","author":"Romani","year":"2012","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.bneo.2025.100090_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12185-012-1208-5","article-title":"The role of T\u03b11 on the infective patients after hematopoietic stem cell transplantation","volume":"97","author":"Ding","year":"2013","journal-title":"Int J Hematol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1532-5415.1989.tb01561.x","article-title":"Augmentation of influenza antibody response in elderly men by thymosin alpha one. A double-blind placebo-controlled clinical study","volume":"37","author":"Gravenstein","year":"1989","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"10.1016\/j.bneo.2025.100090_bib23","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.vaccine.2011.12.014","article-title":"Thymosin-alpha 1 (Zadaxin) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria) in hemodialyzed patients: a pilot study","volume":"30","author":"Carraro","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib24","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12979-023-00334-y","article-title":"Higher plasma levels of thymosin-\u03b11 are associated with a lower waning of humoral response after COVID-19 vaccination: an eight months follow-up study in a nursing home","volume":"20","author":"Pozo-Balado","year":"2023","journal-title":"Immun Ageing"},{"issue":"21","key":"10.1016\/j.bneo.2025.100090_bib25","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1182\/blood.V118.21.1013.1013","article-title":"Thymosin alfa 1 administration improves immune reconstitution and decreases infection-related mortality after HLA-matched sibling T cell-depleted stem cell transplantation","volume":"118","author":"Perruccio","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bneo.2025.100090_bib26","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/0192-0561(94)90081-7","article-title":"Thymosin alpha 1 effects, in vitro, on lymphokine-activated killer cells from patients with primary immunodeficiencies: preliminary results","volume":"16","author":"Eckert","year":"1994","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/j.bneo.2025.100090_bib27","doi-asserted-by":"crossref","first-page":"595395","DOI":"10.3389\/fmolb.2020.595395","article-title":"Epigenetic therapy promotes the ratio of Th1\/Th17 lineage to reverse immune evasion and treat leukemia relapse post-allogeneic stem cell transplantation in non-APL AML patients","volume":"7","author":"Xi","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2025.100090_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/14712598.2018.1474197","article-title":"Serum thymosin alpha 1 levels in normal and pathological conditions","volume":"18","author":"Pica","year":"2018","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bneo.2025.100090_bib29","doi-asserted-by":"crossref","first-page":"873","DOI":"10.3389\/fonc.2019.00873","article-title":"A reappraisal of thymosin alpha1 in cancer therapy","volume":"9","author":"Costantini","year":"2019","journal-title":"Front Oncol"},{"issue":"16","key":"10.1016\/j.bneo.2025.100090_bib30","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1093\/cid\/ciaa630","article-title":"Thymosin alpha 1 reduces the mortality of severe coronavirus disease 2019 by restoration of lymphocytopenia and reversion of exhausted T cells","volume":"71","author":"Liu","year":"2020","journal-title":"Clinical Infectious Diseases"},{"key":"10.1016\/j.bneo.2025.100090_bib31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/BF02985217","article-title":"Thymomodulin: biological properties and clinical applications","volume":"6","author":"Kouttab","year":"1989","journal-title":"Med Oncol Tumor Pharmacother"},{"issue":"10","key":"10.1016\/j.bneo.2025.100090_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14049","article-title":"Thyroid dysfunctions in adult patients after allogeneic hematopoietic stem cell transplantation","volume":"34","author":"Ataca Atilla","year":"2020","journal-title":"Clinical Transplantation"},{"key":"10.1016\/j.bneo.2025.100090_bib33","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1749-6632.1992.tb27461.x","article-title":"Restorative effect of thymomodulin and zinc on interferon-gamma production in aged mice","volume":"673","author":"Grasso","year":"1992","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"10.1016\/j.bneo.2025.100090_bib34","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3109\/08923978809006453","article-title":"The effect of a calf thymus acid lysate on bone marrow cell growth in vitro","volume":"10","author":"Vasilopoulos","year":"1988","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"5","key":"10.1016\/j.bneo.2025.100090_bib35","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1080\/1120009X.1993.11739251","article-title":"Thymomodulin stimulates phagocytosis in vitro by rat macrophages and human polymorphonuclear cells","volume":"5","author":"Braga","year":"1993","journal-title":"J Chemother"},{"issue":"6","key":"10.1016\/j.bneo.2025.100090_bib36","first-page":"331","article-title":"A double-blind clinical trial for the evaluation of the therapeutical effectiveness of a calf thymus derivative (Thymomodulin) in children with recurrent respiratory infections","volume":"8","author":"Fiocchi","year":"1986","journal-title":"Thymus"},{"key":"10.1016\/j.bneo.2025.100090_bib37","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1183\/09031936.93.06010102","article-title":"Thymomodulin increases HLA-DR expression by macrophages but not T-lymphocyte proliferation in autologous mixed leucocyte reaction","volume":"6","author":"Balbi","year":"1993","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.bneo.2025.100090_bib38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1517\/14728220903512991","article-title":"Immunomodulatory role of thymulin in lung diseases","volume":"14","author":"Santos","year":"2010","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bneo.2025.100090_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.intimp.2019.02.042","article-title":"Thymulin treatment attenuates inflammatory pain by modulating spinal cellular and molecular signaling pathways","volume":"70","author":"Nasseri","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.bneo.2025.100090_bib39","doi-asserted-by":"crossref","DOI":"10.1177\/20587384211005645","article-title":"Thymulin and peroxiredoxin 6 have protective effects against streptozotocin-induced type 1 diabetes in mice","volume":"35","author":"Novoselova","year":"2021","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.bneo.2025.100090_bib41","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1749-6632.2008.03964.x","article-title":"The thymus-neuroendocrine axis: physiology, molecular biology, and therapeutic potential of the thymic peptide thymulin","volume":"1153","author":"Reggiani","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"5","key":"10.1016\/j.bneo.2025.100090_bib42","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1159\/000329495","article-title":"Thymulin-based gene therapy and pituitary function in animal models of aging","volume":"18","author":"Reggiani","year":"2011","journal-title":"Neuroimmunomodulation"},{"issue":"1\u20132","key":"10.1016\/j.bneo.2025.100090_bib43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000026362","article-title":"Cytokine-mediated or direct effects of thymulin on the nervous system as assessed by pain-related behavior","volume":"6","author":"Safieh-Garabedian","year":"1999","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bneo.2025.100090_bib44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neulet.2018.11.041","article-title":"Targeting inflammatory components in neuropathic pain: the analgesic effect of thymulin related peptide","volume":"702","author":"Safieh-Garabedian","year":"2019","journal-title":"Neurosci Lett"},{"issue":"5","key":"10.1016\/j.bneo.2025.100090_bib45","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/0896-8411(92)90152-G","article-title":"Thymulin and its role in immunomodulation","volume":"5","author":"Safieh-Garabedian","year":"1992","journal-title":"J Autoimmun"},{"issue":"4","key":"10.1016\/j.bneo.2025.100090_bib46","first-page":"471","article-title":"Neonatal thymulin gene therapy in nude mice: effects on the morphology of the pituitary corticotrope population","volume":"26","author":"Martines","year":"2011","journal-title":"Histol Histopathol"},{"issue":"5","key":"10.1016\/j.bneo.2025.100090_bib47","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1159\/000346477","article-title":"The thymulin-lactotropic axis in rodents: thymectomy, immunoneutralization and gene transfer studies","volume":"20","author":"Martines","year":"2013","journal-title":"Neuroimmunomodulation"},{"issue":"7","key":"10.1016\/j.bneo.2025.100090_bib48","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1089\/dna.2021.0024","article-title":"The emerging role of thymopoietin-antisense RNA 1 as long noncoding RNA in the pathogenesis of human cancers","volume":"40","author":"Zheng","year":"2021","journal-title":"DNA Cell Biol"},{"issue":"4","key":"10.1016\/j.bneo.2025.100090_bib49","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12253-015-9907-x","article-title":"Thymopoietin beta and gamma isoforms as a potential diagnostic molecular marker for breast cancer: preliminary data","volume":"21","author":"Marrero-Rodr\u00edguez","year":"2015","journal-title":"Pathol Oncol Res"},{"issue":"3","key":"10.1016\/j.bneo.2025.100090_bib50","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/jss.400140312","article-title":"Immunoregulation by thymopoietin","volume":"14","author":"Goldstein","year":"1980","journal-title":"J Supramol Struct"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib51","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02985219","article-title":"Immunomodulation with thymopentin: in vitro studies","volume":"6","author":"Duchateau","year":"1989","journal-title":"Med Oncol Tumor Pharmacother"},{"issue":"8324","key":"10.1016\/j.bneo.2025.100090_bib52","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0140-6736(83)92810-6","article-title":"Thymopoietin pentapeptide treatment of primary immunodeficiencies","volume":"1","author":"Aiuti","year":"1983","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.bneo.2025.100090_bib53","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.7150\/jca.30738","article-title":"Clinicopathologic and prognostic significance of thymopoietin-\u03b1 overexpression in gastric cancer","volume":"10","author":"Sun","year":"2019","journal-title":"J Cancer"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12957-016-1018-y","article-title":"Depletion of thymopoietin inhibits proliferation and induces cell cycle arrest\/apoptosis in glioblastoma cells","volume":"14","author":"Zhang","year":"2016","journal-title":"World J Surg Oncol"},{"issue":"5","key":"10.1016\/j.bneo.2025.100090_bib55","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.4049\/jimmunol.120.5.1594","article-title":"Thymopoietin enhances the allogeneic response and cyclic GMP levels of mouse peripheral, thymus-derived lymphocytes1","volume":"120","author":"Sunshine","year":"1978","journal-title":"The Journal of Immunology"},{"issue":"4","key":"10.1016\/j.bneo.2025.100090_bib56","first-page":"261","article-title":"Immunopotentiating and immunotherapeutic effects of thymic hormones and factors with special emphasis on thymic humoral factor THF-gamma2","volume":"19","author":"Ben-Efraim","year":"1999","journal-title":"Crit Rev Immunol"},{"issue":"9","key":"10.1016\/j.bneo.2025.100090_bib57","doi-asserted-by":"crossref","first-page":"140467","DOI":"10.1016\/j.bbapap.2020.140467","article-title":"Degradation of thymic humoral factor \u03b32 in human, rat and mouse blood: an experimental and theoretical study","volume":"1868","author":"Martignoni","year":"2020","journal-title":"Biochim Biophys Acta Proteins Proteom"},{"issue":"4","key":"10.1016\/j.bneo.2025.100090_bib58","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1590-8658(02)80149-9","article-title":"Treatment of chronic hepatitis D with thymus-derived polypeptide thymic humoral factor-gamma 2: a pilot study","volume":"34","author":"Rosina","year":"2002","journal-title":"Dig Liver Dis"},{"issue":"3","key":"10.1016\/j.bneo.2025.100090_bib59","first-page":"155","article-title":"Prospects of AIDS therapy by thymic humoral factor, a thymic hormone","volume":"9","author":"Trainin","year":"1990","journal-title":"Nat Immun Cell Growth Regul"},{"issue":"4","key":"10.1016\/j.bneo.2025.100090_bib60","first-page":"627","article-title":"Thymic humoral factor effect on intracellular lymphocyte cAMP in patients with ankylosing spondylitis","volume":"9","author":"Mutchnick","year":"1982","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.bneo.2025.100090_bib61","first-page":"151","article-title":"Cellular immunity in patients with acquired immunodeficiency syndrome (AIDS) in Israel: effects of THF, a thymic hormone in vitro","volume":"8","author":"Shohat","year":"1986","journal-title":"Thymus"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib62","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0387-7604(83)80006-0","article-title":"Cell mediated immunity and effects of \u201cthymic humoral factor\u201d in 15 patients with SSPE","volume":"5","author":"Handzel","year":"1983","journal-title":"Brain Dev"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib63","first-page":"111","article-title":"The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients","volume":"31","author":"Michalevicz","year":"1978","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0165-2478(93)90160-4","article-title":"Thymic humoral factor, THF-gamma 2, enhances immunotherapy of murine cytomegalovirus (MCMV) infection by both CD4+ and CD8+ immune T cells","volume":"39","author":"Rager-Zisman","year":"1993","journal-title":"Immunol Lett"},{"issue":"4","key":"10.1016\/j.bneo.2025.100090_bib65","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S1665-2681(19)31523-6","article-title":"Protective effect of thymic humoral factor on porcine serum-induced hepatic fibrosis and liver damage in Wistar rats","volume":"10","author":"Osuna-Mart\u00ednez","year":"2011","journal-title":"Ann Hepatol"},{"issue":"4","key":"10.1016\/j.bneo.2025.100090_bib66","first-page":"423","article-title":"THF, a thymic hormone, promotes interleukin-2 production in intact and thymus-deprived mice","volume":"3","author":"Umiel","year":"1984","journal-title":"J Biol Response Mod"},{"issue":"6B","key":"10.1016\/j.bneo.2025.100090_bib67","first-page":"4473","article-title":"Thymic humoral factor-gamma 2 augments immune cell response and exerts antitumor activity in murine model systems","volume":"20","author":"Beuth","year":"2000","journal-title":"Anticancer Res"},{"issue":"2","key":"10.1016\/j.bneo.2025.100090_bib68","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/08923979609052733","article-title":"Thymic humoral factor-gamma 2 (THF-gamma 2) immunotherapy reduces the metastatic load and restores immunocompetence in 3LL tumor-bearing mice receiving anticancer chemotherapy","volume":"18","author":"Ophir","year":"1996","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"7","key":"10.1016\/j.bneo.2025.100090_bib69","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0192-0561(86)90001-9","article-title":"Thymosin alpha 1 and thymosin beta 4 in serum: comparison of normal, cord, homosexual and AIDS serum","volume":"8","author":"Naylor","year":"1986","journal-title":"Int J Immunopharmacol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/hyb.1987.6.47","article-title":"Localization of thymosin alpha 1 production to thymus medullary epithelial cells by use of monoclonal antibodies","volume":"6","author":"Oates","year":"1987","journal-title":"Hybridoma"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib71","first-page":"45","article-title":"Serum levels of immunoreactive thymosin alpha 1 and thymosin beta 4 in large cohorts of healthy adults","volume":"19","author":"Weller","year":"1992","journal-title":"Thymus"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib72","first-page":"6","article-title":"Comprehensive review of the safety and efficacy of thymosin alpha 1 in human clinical trials","volume":"30","author":"Dinetz","year":"2024","journal-title":"Altern Ther Health Med"},{"issue":"12","key":"10.1016\/j.bneo.2025.100090_bib73","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/0277-5379(87)90059-9","article-title":"A calf thymus acid lysate improves clinical symptoms and T-cell defects in the early stages of HIV infection: second report","volume":"23","author":"Valesini","year":"1987","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib74","first-page":"21","article-title":"Thymomodulin increases the depressed production of superoxide anion by alveolar macrophages in patients with chronic bronchitis","volume":"11","author":"Maiorano","year":"1989","journal-title":"Int J Tissue React"},{"issue":"3","key":"10.1016\/j.bneo.2025.100090_bib75","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1210\/jcem-62-3-474","article-title":"Thyroid function modulates thymic endocrine activity","volume":"62","author":"Fabris","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/j.bneo.2025.100090_bib76","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1017\/S0007114507832880","article-title":"The thymus is a common target in malnutrition and infection","volume":"98","author":"Savino","year":"2007","journal-title":"British Journal of Nutrition"},{"key":"10.1016\/j.bneo.2025.100090_bib77","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.948488","article-title":"Thymus, undernutrition, and infection: approaching cellular and molecular interactions","volume":"9","author":"Savino","year":"2022","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.bneo.2025.100090_bib78","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/ajcn\/42.2.275","article-title":"Thymulin (Zn-facteur thymique serique) activity in anorexia nervosa patients","volume":"42","author":"Wade","year":"1985","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib79","first-page":"55","article-title":"Evidence that appearance of thymulin in plasma follows lymphoid chimerism and precedes development of immunity in patients with lethal combined immunodeficiency transplanted with T cell-depleted haploidentical marrow","volume":"50","author":"Incefy","year":"1990","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.bneo.2025.100090_bib80","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI113717","article-title":"Serum thymulin in human zinc deficiency","volume":"82","author":"Prasad","year":"1988","journal-title":"J Clin Invest"},{"issue":"25","key":"10.1016\/j.bneo.2025.100090_bib81","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1182\/blood.2021013950","article-title":"Activation of the zinc-sensing receptor GPR39 promotes T-cell reconstitution after hematopoietic cell transplant in mice","volume":"139","author":"Iovino","year":"2022","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bneo.2025.100090_bib82","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1073\/pnas.74.6.2541","article-title":"Bioassay determinations of thymopoietin and thymic hormone levels in human plasma","volume":"74","author":"Twomey","year":"1977","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.bneo.2025.100090_bib83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/039463209100400101","article-title":"Immunomodulatory effect and acetylcholine receptor binding of a thymopeptide (Tp4) on human peripheral blood lymphocytes","volume":"4","author":"Szel\u00e9nyi","year":"1991","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib84","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0003-9861(84)90338-2","article-title":"Thymopoietin radioreceptor assay utilizing lectin-purified glycoprotein from a biologically responsive T cell line","volume":"234","author":"Audhya","year":"1984","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"10.1016\/j.bneo.2025.100090_bib85","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0190-9622(83)70042-3","article-title":"Thymopoietin pentapeptide (TP-5) improves clinical parameters and lymphocyte subpopulations in atopic dermatitis","volume":"8","author":"Kang","year":"1983","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.bneo.2025.100090_bib86","first-page":"1195","article-title":"Attempted treatment of acquired immunodeficiency syndrome (AIDS) with thymic humoral factor","volume":"20","author":"Berner","year":"1984","journal-title":"Isr J Med Sci"},{"issue":"106","key":"10.1016\/j.bneo.2025.100090_bib87","article-title":"Clinical experience of thymic regeneration with thymus extracts, thymic peptides and stem cells in general medicine, oncology and anti-aging medicine: a review","volume":"9","author":"Chan","year":"2023","journal-title":"HSOA J Stem Cells Res Dev Ther"},{"issue":"2","key":"10.1016\/j.bneo.2025.100090_bib88","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/cei\/uxac105","article-title":"IL-2-based approaches to Treg enhancement","volume":"211","author":"Harris","year":"2023","journal-title":"Clin Exp Immunol"},{"issue":"5","key":"10.1016\/j.bneo.2025.100090_bib89","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cytogfr.2010.09.002","article-title":"Biology of interleukin-10","volume":"21","author":"Sabat","year":"2010","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.bneo.2025.100090_bib90","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.cytogfr.2019.05.001","article-title":"TNFR2 signaling modulates immunity after allogeneic hematopoietic cell transplantation","volume":"47","author":"Mancusi","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"issue":"6","key":"10.1016\/j.bneo.2025.100090_bib91","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1093\/stmcls\/sxac021","article-title":"Graft-versus-solid-tumor effect: from hematopoietic stem cell transplantation to adoptive cell therapies","volume":"40","author":"Barisic","year":"2022","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib92","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1182\/blood.V94.1.333.413a31_333_339","article-title":"Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation","volume":"94","author":"Ruggeri","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.bneo.2025.100090_bib93","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/bmt.2010.117","article-title":"Inflammatory cytokine inhibition with combination daclizumab and infliximab for steroid-refractory acute GVHD","volume":"46","author":"Rager","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bneo.2025.100090_bib94","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1182\/blood-2003-12-4241","article-title":"Tumor necrosis factor-alpha blockade for the treatment of acute GVHD","volume":"104","author":"Couriel","year":"2004","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.bneo.2025.100090_bib95","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1182\/blood-2010-05-283887","article-title":"IFN-\u03b3 promotes graft-versus-leukemia effects without directly interacting with leukemia cells in mice after allogeneic hematopoietic cell transplantation","volume":"118","author":"Yang","year":"2011","journal-title":"Blood"},{"issue":"15","key":"10.1016\/j.bneo.2025.100090_bib96","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1182\/blood-2008-07-168419","article-title":"Paradoxical effects of IFN-gamma in graft-versus-host disease reflect promotion of lymphohematopoietic graft-versus-host reactions and inhibition of epithelial tissue injury","volume":"113","author":"Wang","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.bneo.2025.100090_bib97","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/14712598.2017.1269167","article-title":"Novel strategies for improving hematopoietic reconstruction after allogeneic hematopoietic stem cell transplantation or intensive chemotherapy","volume":"17","author":"Baron","year":"2017","journal-title":"Expert Opin Biol Ther"},{"issue":"1","key":"10.1016\/j.bneo.2025.100090_bib98","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1182\/blood-2004-09-3728","article-title":"Use of glycosylated recombinant human G-CSF (lenograstim) during and\/or after induction chemotherapy in patients 61 years of age and older with acute myeloid leukemia: final results of AML-13, a randomized phase-3 study","volume":"106","author":"Amadori","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.bneo.2025.100090_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008238.pub3","article-title":"Colony-stimulating factors for prevention and treatment of infectious complications in patients with acute myelogenous leukemia","author":"Gurion","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Blood Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950328025000251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T09:14:49Z","timestamp":1755767689000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950328025000251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":98,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2950328025000251"],"URL":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100090","relation":{},"ISSN":["2950-3280"],"issn-type":[{"value":"2950-3280","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymic peptides in immune reconstitution and clinical outcome after allogeneic hematopoietic cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Blood Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bneo.2025.100090","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100090"}}